Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -8.201% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) Cc1ccc(CCN2CC(C(=O)NCCCOC(C)C)CC2=O)cc1
b.) CN(C)c1ccc(NC(=O)CN2CCc3ccccc3C2)cc1
Answer: a. Cc1ccc(CCN2CC(C(=O)NCCCOC(C)C)CC2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(CCN2CC(C(=O)NCCCOC(C)C)CC2=O)cc1
Cc1ccc(CCN2CC(C(=O)NCCCOC(C)C)CC2=O)cc1
1-[2-(4-methylphenyl)ethyl]-5-oxo-N-(3-propan-2-yloxypropyl)pyrrolidine-3-carboxamide